VECTRA-01

AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)

Actinium (225Ac) zadavotide guraxetan (AZD2265 [FPI-2265])OngoingRecruitingPhase 3Open NCT07611110 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…